Comparison of tumor blood by perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 3, 2005, Pages 272-281

  Graff, Bjørn A ^a   Benjaminsen, Ilana C ^a   Brurberg, Kjetil G ^a   Ruud, Else Beate M ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Blood flow; Dynamic contrast enhanced MRI; Kety analysis; Melanoma; Perfusion imaging

Indexed keywords

GADOLINIUM; PENTETIC ACID; RUBIDIUM CHLORIDE RB 86; TECHNETIUM 99M; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; INVASIVE IMAGING; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR XENOGRAFT;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MELANOMA, AMELANOTIC; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 14044279276     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20265     Document Type: Article

References (52)

1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-6465.
2. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58:1408-1416.
3. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997;4:1-23.
4. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-276.
5. Griebel J, Mayr NA, de Vries A, et al. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 1997;7:111-119.
6. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millenium. J Magn Reson Imaging 1999;10:903-907.
7. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598-3602.
8. Mayr NA, Yuh WT, Arnholt JC, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000;12:1027-1033.
9. Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 2000;216:803-809.
10. Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997;7:461-464.
11. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kydo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841-848.
12. Cooper RA, Carrington BM, Loncaster JA, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 2000;57:53-59.
13. Lyng H, Vorren AO, Sundfør K, et al. Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging. J Magn Reson Imaging 2001;14:750-756.
14. Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759-767.
15. de Vries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:958-965.
16. Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution DCE-MRI: a preclinical study of human melanoma xenografts. Magn Reson Med 2004;52:269-276.
17. Larsson HBW, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 1994;4:433-440.
18. Larsson HBW, Fritz-Hansen T, Rostrup E, et al. Myocardial perfusion modelling using MRI. Magn Reson Med 1996;35:716-726.
19. 1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
20. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
21. Graff BA, Kvinnsland Y, Skretting A, Rofstad EK. Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. Br J Cancer 2003;88:291-297.
22. Rofstad EK. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer 1994; 70:804-812.
23. Tufto I, Lyng H, Rofstad EK. Vascular density in human melanoma xenografts: relationship to angiogenesis, perfusion and necrosis. Cancer Lett 1998;123:159-165.
24. Tufto I, Rofstad EK. Interstitial fluid pressure, fraction of necrotic tumor tissue, and tumor cell density in human melanoma xenografts. Acta Oncol 1998;37:291-297.
25. Rofstad EK, Steinsland E, Kaalhus O, Chang YB, Høvik B, Lyng H. Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue. Int J Radiat Biol 1994;65:387-401.
26. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571.
27. Graff BA, Vangberg L, Rofstad EK. Quantitative assessment of uptake and distribution of iron oxide particles (NC 100150) in human melanoma xenografts by contrast-enhanced MRI. Magn Reson Med 2004;51:727-735.
28. Kety S. Theory of blood-tissue exchange and its application to measurements of blood flow. Methods Med Res 1960;8:228-236.
29. Appelgren LK. Methods of recording tumor blood flow. In: Peterson HI, editor. Tumor blood circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors. Boca Raton: CRC Press; 1979. p 87-101.
30. Lyng H, Skretting A, Rofstad EK. Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res 1992;52:584-592.
31. Pahernik S, Griebel J, Botzlar A, et al. Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging. Br J Cancer 2001;85:1655-1663.
32. Bogin L, Margalit R, Mispelter J, Degani H. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging 2002;16:289-299.
33. Kiessling F, Heilmann M, Vosseler S, et al. Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging. Int J Cancer 2003;104:113-120.
34. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
35. Weinmann H-J, Brasch RC, Press W-R, Wesbey GB. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142:619-624.
36. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992;23:239-253.
37. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993;30:337-346.
38. Bjørnæs I, Rofstad EK. Microvascular permeability to macromolecules in human melanoma xenografts assessed by contrast-enhanced MRI - intertumor and intratumor heterogeneity. Magn Reson Imaging 2001;19:723-730.
39. 86Rb. Cancer Res 1974;34:1451-1456.
40. Kjartansson I. Tumor circulation. An experimental study in the rat with a comparison of different methods for estimation of tumor blood flow. Acta Chir Scand 1976;471:1-74.
41. Tozer GM, Shaffi KM. Modification of tumor blood flow using the hypertensive agent, angiotensin II. Br J Cancer 1993;67:981-988.
42. Kaplan HM, Brewer NR, Blair WH. Physiology. In: Foster HL, Small JD, Fox JG, editors. The mouse in biomedical research. New York: Academic Press; 1983. p 247-292.
43. Trotter MJ, Chaplin DJ, Durand RE, Olive PL. The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int J Radiat Oncol Biol Phys 1989;16:931-934.
44. Pigott KH, Hill SA, Chaplin DJ, Saunders MI. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother Oncol 1996;40:45-50.
45. Mäntylä M, Heikkonen J, Perkkiö J. Regional blood flow in human tumours measured with argon, krypton and xenon. Br J Radiol 1988;61:379-382.
46. Waterman FM, Nerlinger RE, Moylan DJ, Leeper DB. Response of human tumor blood flow to local hyperthermia. Int J Radiat Oncol Biol Phys 1987;13:75-82.
47. trans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. J Magn Reson Imaging 2004;19:527-536.
48. Galbraith SM, Maxwell RJ, Lodge MA, et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 2003;21:2807-2809.
49. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature In breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420-429.
50. Daldrup HE, Shames DM, Husseini W, Wendland MF, Okuhata Y, Brasch RC. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries. Magn Reson Med 1998;40:537-543.
51. Zhou R, Pickup S, Yankeelov TE, Springer Jr CS, Glickson JD. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn Reson Med 2004;52:248-257.
52. Graff BA, Bjørnæs I, Rofstad EK. Macromolecule uptake in human melanoma xenografts: relationships to blood supply, vascular density, microvessel permeability and extracellular volume fraction. Eur J Cancer 2000;36:1433-1440.